Page last updated: 2024-08-24

oseltamivir and meropenem

oseltamivir has been researched along with meropenem in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Fasanello, J; Hereth, J; Sharp, JK	1
Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N	1

Reviews

1 review(s) available for oseltamivir and meropenem

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for oseltamivir and meropenem

Article	Year
Bronchoscopic findings in a child with pandemic novel H1N1 influenza A and methicillin-resistant Staphylococcus aureus. Pediatric pulmonology, 2011, Volume: 46, Issue:1 Topics: Anti-Bacterial Agents; Bronchoscopy; Child; Fatal Outcome; Female; Fibrinolytic Agents; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung; Meropenem; Methicillin-Resistant Staphylococcus aureus; Oseltamivir; Respiratory Distress Syndrome; Respiratory Insufficiency; Staphylococcal Infections; Thienamycins; Tissue Plasminogen Activator; Vancomycin	2011
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2020, Volume: 28, Issue:2 Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin	2020

Article

Year

Bronchoscopic findings in a child with pandemic novel H1N1 influenza A and methicillin-resistant Staphylococcus aureus.

Pediatric pulmonology, 2011, Volume: 46, Issue:1

Topics: Anti-Bacterial Agents; Bronchoscopy; Child; Fatal Outcome; Female; Fibrinolytic Agents; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Lung; Meropenem; Methicillin-Resistant Staphylococcus aureus; Oseltamivir; Respiratory Distress Syndrome; Respiratory Insufficiency; Staphylococcal Infections; Thienamycins; Tissue Plasminogen Activator; Vancomycin

2011

The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 2020, Volume: 28, Issue:2

Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin

2020